Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

73.62
-0.4900-0.66%
Post-market: 74.000.3800+0.52%19:30 EDT
Volume:1.44M
Turnover:106.88M
Market Cap:10.23B
PE:-10.25
High:75.10
Open:73.23
Low:73.13
Close:74.11
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.00
PE(LYR):-11.26

Loading ...

Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price of $650 Mln - SEC Filing

THOMSON REUTERS
·
May 06

Cytokinetics plans $650 million common stock offering

Reuters
·
May 06

Earnings Flash (CYTK) Cytokinetics Posts Q1 Loss $1.67, vs. FactSet Est of $1.65 Loss

MT Newswires Live
·
May 06

Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline

TIPRANKS
·
May 06

Cytokinetics Q1 revenue jumps on MYQORZO launch

Reuters
·
May 06

Cytokinetics director Wendell Wierenga sells 4,032 shares for $302,400

Reuters
·
May 06

Cytokinetics Q1 EPS $(1.67) Misses $(1.64) Estimate, Sales $19.355M Beat $8.518M Estimate.

Benzinga Earnings
·
May 06

Cytokinetics CFO Sung Lee sells 23,906 shares for $1.84 million

Reuters
·
May 06

Cytokinetics Inc - Announces Proposed $650 Mln Common Stock Offering

THOMSON REUTERS
·
May 06

Cytokinetics EVP, Chief Commercial Officer Andrew Callos disposes 11,333 shares for $875,372.25

Reuters
·
May 06

BRIEF-Cytokinetics Q1 Basic EPS USD -1.67

Reuters
·
May 06

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 06

Cytokinetics Is Maintained at Buy by Needham

Dow Jones
·
May 06

Cytokinetics Shares Surge Over 20% on Positive Heart Drug Trial Results

Stock News
·
May 05

Cytokinetics price target raised to $106 from $92 at Truist

TIPRANKS
·
May 05

Cytokinetics report ‘arguably a best-case scenario’ for Edgewise, says Stifel

TIPRANKS
·
May 05

Cytokinetics Phase 3 data bodes well for Edgewise, says Raymond James

TIPRANKS
·
May 05

Cytokinetics Shares Jump 15.8% After Heart Disease Drug Meets Main Goals in Late-Stage Study

THOMSON REUTERS
·
May 05

This Is Why Cytokinetics Stock (CYTK) Soared Today

TIPRANKS
·
May 05

Cytokinetics Rises After Promising Late-Stage Trial of Heart Drug

Dow Jones
·
May 05